WENDY KEITEL

TitleProfessor
InstitutionBaylor College of Medicine
DepartmentDepartment of Molecular Virology & Microbiology
AddressOne Baylor Plaza
Houston, TX 77030
vCardDownload vCard
    Other Positions
    TitleProfessor
    InstitutionBaylor College of Medicine
    DepartmentDepartment of Medicine
    DivisionMedicine-Infectious Disease


    Collapse Research 
    Collapse research activities and funding
    N01AI025135     (KEITEL, WENDY A)Dec 20, 1991 - Sep 30, 1998
    NIH/NIAID
    EVALUATION OF INFECTIOUS DISEASE CONTROL
    Role: Principal Investigator

    N01AI000000     (HOLMES, MELYNDA)Apr 1, 2012 - Sep 30, 2019
    NIH/NIAID
    DMID CLINICAL RESEARCH OPERATIONS AND MANAGEMENT SUPPORT
    Role: Co-Principal Investigator

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. El Sahly HM, Atmar RL, Sendra E, Wegel A, Keitel WA. Topical Imiquimod Does not Provide an Adjuvant Effect when Administered with Inactivated Influenza A/H5N1 Vaccine in Healthy Young Adults. J Infect Dis. 2021 Apr 14. PMID: 33852718.
      Citations:    Fields:    
    2. Salerno-Gonçalves R, Chen WH, Mulligan MJ, Frey SE, Stapleton JT, Keitel WA, Bailey J, Sendra E, Hill H, Johnson RA, Sztein MB. Vaccine-related major cutaneous reaction size correlates with cellular-mediated immune responses after tularaemia immunisation. Clin Transl Immunology. 2021; 10(1):e1239. PMID: 33505681.
      Citations: 1     
    3. Munoz FM, Patel SM, Jackson LA, Swamy GK, Edwards KM, Frey SE, Petrie CR, Sendra EA, Keitel WA. Safety and immunogenicity of three seasonal inactivated influenza vaccines among pregnant women and antibody persistence in their infants. Vaccine. 2020 07 14; 38(33):5355-5363. PMID: 32571718.
      Citations: 1     Fields:    Translation:Humans
    4. El Sahly HM, Makedonas G, Corry D, Atmar RL, Bellamy A, Cross K, Keitel WA. An evaluation of cytokine and cellular immune responses to heterologous prime-boost vaccination with influenza A/H7N7-A/H7N9 inactivated vaccine. Hum Vaccin Immunother. 2020 12 01; 16(12):3138-3145. PMID: 32401699.
      Citations: 1     Fields:    Translation:HumansAnimalsCellsPHPublic Health
    5. Lai L, Rouphael N, Xu Y, Sherman AC, Edupuganti S, Anderson EJ, Lankford-Turner P, Wang D, Keitel W, McNeal MM, Cross K, Hill H, Bellamy AR, Mulligan MJ. Baseline Levels of Influenza-Specific B Cells and T Cell Responses Modulate Human Immune Responses to Swine Variant Influenza A/H3N2 Vaccine. Vaccines (Basel). 2020 Mar 13; 8(1). PMID: 32183105.
      Citations:    
    6. Keitel WA, Atmar RL. Corrigendum to : Influenza Vaccines After 7 Decades: Still on the Learning Curve. J Infect Dis. 2020 02 03; 221(4):679. PMID: 31747019.
      Citations:    Fields:    
    7. Atmar RL, Keitel WA. Searching for Improved Flu Vaccines-The Time Is Now. J Infect Dis. 2020 01 01; 221(1):1-4. PMID: 31665360.
      Citations: 1     Fields:    Translation:HumansCells
    8. Bower WA, Schiffer J, Atmar RL, Keitel WA, Friedlander AM, Liu L, Yu Y, Stephens DS, Quinn CP, Hendricks K. Use of Anthrax Vaccine in the United States: Recommendations of the Advisory Committee on Immunization Practices, 2019. MMWR Recomm Rep. 2019 12 13; 68(4):1-14. PMID: 31834290.
      Citations: 7     Fields:    Translation:HumansPHPublic Health
    9. Keitel WA, Atmar RL. Influenza Vaccines After 7 Decades: Still on the Learning Curve. J Infect Dis. 2019 09 13; 220(8):1240-1242. PMID: 30561693.
      Citations:    Fields:    Translation:Humans
    10. Keitel WA, Potter GE, Diemert D, Bethony J, El Sahly HM, Kennedy JK, Patel SM, Plieskatt JL, Jones W, Deye G, Bottazzi ME, Hotez PJ, Atmar RL. A phase 1 study of the safety, reactogenicity, and immunogenicity of a Schistosoma mansoni vaccine with or without glucopyranosyl lipid A aqueous formulation (GLA-AF) in healthy adults from a non-endemic area. Vaccine. 2019 10 08; 37(43):6500-6509. PMID: 31515141.
      Citations: 12     Fields:    Translation:HumansAnimalsCTClinical Trials
    11. Munoz FM, Anderson EJ, Bernstein DI, Harrison CJ, Pahud B, Anderson E, Creech CB, Berry AA, Kotloff KL, Walter EB, Atmar RL, Bellamy AR, Chang S, Keitel WA. Safety and immunogenicity of unadjuvanted subvirion monovalent inactivated influenza H3N2 variant (H3N2v) vaccine in children and adolescents. Vaccine. 2019 08 23; 37(36):5161-5170. PMID: 31375440.
      Citations: 1     Fields:    Translation:HumansCellsCTClinical Trials
    12. Keitel WA, Voronca DC, Atmar RL, Paust S, Hill H, Wolff MC, Bellamy AR. Effect of recent seasonal influenza vaccination on serum antibody responses to candidate pandemic influenza A/H5N1 vaccines: A meta-analysis. Vaccine. 2019 09 03; 37(37):5535-5543. PMID: 31160101.
      Citations: 1     Fields:    Translation:HumansCellsPHPublic Health
    13. El Sahly HM, Atmar RL, Patel SM, Bellamy A, Liu L, Hong W, Zhu H, Guan Y, Keitel WA. Safety and immunogenicity of an 8 year interval heterologous prime-boost influenza A/H7N7-H7N9 vaccination. Vaccine. 2019 05 01; 37(19):2561-2568. PMID: 30955980.
      Citations: 1     Fields:    Translation:HumansCellsPHPublic Health
    14. El Sahly HM, Gorchakov R, Lai L, Natrajan MS, Patel SM, Atmar RL, Keitel WA, Hoft DF, Barrett J, Bailey J, Edupuganti S, Raabe V, Wu HM, Fairley J, Rouphael N, Murray KO, Mulligan MJ. Clinical, Virologic, and Immunologic Characteristics of Zika Virus Infection in a Cohort of US Patients: Prolonged RNA Detection in Whole Blood. Open Forum Infect Dis. 2019 Jan; 6(1):ofy352. PMID: 30697574.
      Citations: 10     
    15. Munoz FM, Jackson LA, Swamy GK, Edwards KM, Frey SE, Stephens I, Ault K, Winokur P, Petrie CR, Wolff M, Patel SM, Keitel WA. Safety and immunogenicity of seasonal trivalent inactivated influenza vaccines in pregnant women. Vaccine. 2018 12 18; 36(52):8054-8061. PMID: 30416018.
      Citations: 5     Fields:    Translation:HumansPHPublic Health
    16. Jackson LA, El Sahly HM, George S, Winokur P, Edwards K, Brady RC, Rouphael N, Keitel WA, Mulligan MJ, Burton RL, Nakamura A, Ferreria J, Nahm MH. Randomized clinical trial of a single versus a double dose of 13-valent pneumococcal conjugate vaccine in adults 55 through 74?years of age previously vaccinated with 23-valent pneumococcal polysaccharide vaccine. Vaccine. 2018 01 29; 36(5):606-614. PMID: 29279281.
      Citations: 3     Fields:    Translation:HumansCellsPHPublic Health
    17. Mulligan MJ, Stapleton JT, Keitel WA, Frey SE, Chen WH, Rouphael N, Edupuganti S, Beck A, Winokur PL, El Sahly HM, Patel SM, Atmar RL, Graham I, Anderson E, El-Kamary SS, Pasetti MF, Sztein MB, Hill H, Goll JB. Tularemia vaccine: Safety, reactogenicity, "Take" skin reactions, and antibody responses following vaccination with a new lot of the Francisella tularensis live vaccine strain - A phase 2 randomized clinical Trial. Vaccine. 2017 08 24; 35(36):4730-4737. PMID: 28750854.
      Citations: 9     Fields:    Translation:HumansCellsPHPublic HealthCTClinical Trials
    18. Jackson LA, Frey SE, El Sahly HM, Mulligan MJ, Winokur PL, Kotloff KL, Campbell JD, Atmar RL, Graham I, Anderson EJ, Anderson EL, Patel SM, Fields C, Keitel W, Rouphael N, Hill H, Goll JB. Safety and immunogenicity of a modified vaccinia Ankara vaccine using three immunization schedules and two modes of delivery: A randomized clinical non-inferiority trial. Vaccine. 2017 03 23; 35(13):1675-1682. PMID: 28256358.
      Citations: 5     Fields:    Translation:HumansCellsCTClinical Trials
    19. Balderas MA, Nguyen CT, Terwilliger A, Keitel WA, Iniguez A, Torres R, Palacios F, Goulding CW, Maresso AW. Progress toward the Development of a NEAT Protein Vaccine for Anthrax Disease. Infect Immun. 2016 Dec; 84(12):3408-3422. PMID: 27647868.
      Citations: 6     Fields:    Translation:AnimalsCells
    20. Edwards KM, Keitel WA. Challenges Remain for Influenza Vaccination of Children. J Infect Dis. 2016 11 15; 214(10):1470-1472. PMID: 27571903.
      Citations:    Fields:    Translation:HumansPHPublic Health
    21. Feldstein LR, Matrajt L, Elizabeth Halloran M, Keitel WA, Longini IM. Extrapolating theoretical efficacy of inactivated influenza A/H5N1 virus vaccine from human immunogenicity studies. Vaccine. 2016 07 19; 34(33):3796-802. PMID: 27268778.
      Citations: 3     Fields:    Translation:HumansCells
    22. Quinn CP, Sabourin CL, Schiffer JM, Niemuth NA, Semenova VA, Li H, Rudge TL, Brys AM, Mittler RS, Ibegbu CC, Wrammert J, Ahmed R, Parker SD, Babcock J, Keitel W, Poland GA, Keyserling HL, El Sahly H, Jacobson RM, Marano N, Plikaytis BD, Wright JG. Humoral and Cell-Mediated Immune Responses to Alternate Booster Schedules of Anthrax Vaccine Adsorbed in Humans. Clin Vaccine Immunol. 2016 Apr; 23(4):326-38. PMID: 26865594.
      Citations: 2     Fields:    Translation:HumansCells
    23. Mbawuike IN, Atmar RL, Patel SM, Corry DB, Winokur PL, Brady RC, Chen WH, Edwards KM, Creech CB, Walter EB, Frey SE, Belshe RB, Goll JB, Hill H, Keitel WA. Cell mediated immune responses following revaccination with an influenza A/H5N1 vaccine. Vaccine. 2016 Jan 20; 34(4):547-554. PMID: 26657997.
      Citations: 1     Fields:    Translation:HumansCellsCTClinical Trials
    24. Chen WH, Jackson LA, Edwards KM, Keitel WA, Hill H, Noah DL, Creech CB, Patel SM, Mangal B, Kotloff KL. Persistence of Antibody to Influenza A/H5N1 Vaccine Virus: Impact of AS03 Adjuvant. Clin Vaccine Immunol. 2016 01; 23(1):73-7. PMID: 26561390.
      Citations: 6     Fields:    Translation:HumansCellsPHPublic Health
    25. Atmar RL, Keitel WA. Influenza Vaccination of Patients Receiving Statins: Where Do We Go From Here? J Infect Dis. 2016 Apr 15; 213(8):1211-3. PMID: 26516140.
      Citations: 2     Fields:    Translation:Humans
    26. Jackson LA, Campbell JD, Frey SE, Edwards KM, Keitel WA, Kotloff KL, Berry AA, Graham I, Atmar RL, Creech CB, Thomsen IP, Patel SM, Gutierrez AF, Anderson EL, El Sahly HM, Hill H, Noah DL, Bellamy AR. Effect of Varying Doses of a Monovalent H7N9 Influenza Vaccine With and Without AS03 and MF59 Adjuvants on Immune Response: A Randomized Clinical Trial. JAMA. 2015 Jul 21; 314(3):237-46. PMID: 26197184.
      Citations: 54     Fields:    Translation:HumansCellsCTClinical Trials
    27. Frey SE, Wald A, Edupuganti S, Jackson LA, Stapleton JT, El Sahly H, El-Kamary SS, Edwards K, Keyserling H, Winokur P, Keitel W, Hill H, Goll JB, Anderson EL, Graham IL, Johnston C, Mulligan M, Rouphael N, Atmar R, Patel S, Chen W, Kotloff K, Creech CB, Chaplin P, Belshe RB. Comparison of lyophilized versus liquid modified vaccinia Ankara (MVA) formulations and subcutaneous versus intradermal routes of administration in healthy vaccinia-naïve subjects. Vaccine. 2015 Sep 22; 33(39):5225-34. PMID: 26143613.
      Citations: 8     Fields:    Translation:HumansCTClinical Trials
    28. Winokur PL, Patel SM, Brady R, Chen WH, El-Kamary SS, Edwards K, Creech CB, Frey S, Keitel WA, Belshe R, Walter E, Bellamy A, Hill H. Safety and Immunogenicity of a Single Low Dose or High Dose of Clade 2 Influenza A(H5N1) Inactivated Vaccine in Adults Previously Primed With Clade 1 Influenza A(H5N1) Vaccine. J Infect Dis. 2015 Aug 15; 212(4):525-30. PMID: 25712967.
      Citations: 7     Fields:    Translation:HumansCellsCTClinical Trials
    29. Keitel WA, Jackson LA, Edupuganti S, Winokur PL, Mulligan MJ, Thornburg NJ, Patel SM, Rouphael NG, Lai L, Bangaru S, McNeal MM, Bellamy AR, Hill HR. Safety and Immunogenicity of a Subvirion Monovalent Unadjuvanted Inactivated Influenza A(H3N2) Variant Vaccine in Healthy Persons =18 Years Old. J Infect Dis. 2015 Aug 15; 212(4):552-61. PMID: 25649171.
      Citations: 4     Fields:    Translation:HumansCells
    30. Frey SE, Bernstein DI, Brady RC, Keitel WA, El Sahly H, Rouphael NG, Mulligan MJ, Atmar RL, Edupuganti S, Patel SM, Dickey M, Graham I, Anderson EL, Noah DL, Hill H, Wolff M, Belshe RB. Phase II trial in adults of concurrent or sequential 2009 pandemic H1N1 and 2009-2010 seasonal trivalent influenza vaccinations. Vaccine. 2015 Jan 01; 33(1):163-73. PMID: 25444805.
      Citations: 2     Fields:    Translation:HumansPHPublic HealthCTClinical Trials
    31. Chen WH, Jackson LA, Edwards KM, Keitel WA, Hill H, Noah DL, Creech CB, Patel SM, Mangal B, Kotloff KL. Safety, Reactogenicity, and Immunogenicity of Inactivated Monovalent Influenza A(H5N1) Virus Vaccine Administered With or Without AS03 Adjuvant. Open Forum Infect Dis. 2014 Dec; 1(3):ofu091. PMID: 25734159.
      Citations: 13     
    32. Pondo T, Rose CE, Martin SW, Keitel WA, Keyserling HL, Babcock J, Parker S, Jacobson RM, Poland GA, McNeil MM. Evaluation of sex, race, body mass index and pre-vaccination serum progesterone levels and post-vaccination serum anti-anthrax protective immunoglobulin G on injection site adverse events following anthrax vaccine adsorbed (AVA) in the CDC AVA human clinical trial. Vaccine. 2014 Jun 12; 32(28):3548-54. PMID: 24768633.
      Citations: 8     Fields:    Translation:HumansCTClinical Trials
    33. Wright JG, Plikaytis BD, Rose CE, Parker SD, Babcock J, Keitel W, El Sahly H, Poland GA, Jacobson RM, Keyserling HL, Semenova VA, Li H, Schiffer J, Dababneh H, Martin SK, Martin SW, Marano N, Messonnier NE, Quinn CP. Effect of reduced dose schedules and intramuscular injection of anthrax vaccine adsorbed on immunological response and safety profile: a randomized trial. Vaccine. 2014 Feb 12; 32(8):1019-28. PMID: 24373307.
      Citations: 16     Fields:    Translation:Humans
    34. Keitel WA, Piedra PA. Influenza A(H5N1) vaccines: are we better prepared for the next pandemic? J Infect Dis. 2014 Jan 01; 209(1):1-3. PMID: 24158956.
      Citations: 3     Fields:    Translation:HumansAnimalsCells
    35. Pan Y, Rose CE, Haber M, Ma Y, Carrasco JL, Stewart B, Keitel WA, Keyserling H, Jacobson RM, Poland G, McNeil MM. Assessing agreement of repeated binary measurements with an application to the CDC's anthrax vaccine clinical trial. Int J Biostat. 2013 Jul 27; 9(1). PMID: 23898025.
      Citations: 3     Fields:    Translation:Humans
    36. Keitel WA, Dai Z, Awe RW, Atmar RL, Morris S, Schneerson R, Robbins JB. Effects of infection and disease with Mycobacterium tuberculosis on serum antibody to glucan and arabinomannan: two surface polysaccharides of this pathogen. BMC Infect Dis. 2013 Jun 19; 13:276. PMID: 23783070.
      Citations: 3     Fields:    Translation:HumansCells
    37. Keitel WA, Piedra PA, Atmar RL, Demmler G, El Sahly HM, Barrett J, Halpin RA, Lagos R, Fisher-Hoch S, Munoz F. Rapid research response to the 2009 A(H1N1)pdm09 influenza pandemic (Revised). BMC Res Notes. 2013 May 03; 6:177. PMID: 23641940.
      Citations:    Fields:    Translation:HumansCells
    38. Morrison VA, Oxman MN, Levin MJ, Schmader KE, Guatelli JC, Betts RF, Gelb LD, Pachucki CT, Keay SK, Menzies B, Griffin MR, Kauffman CA, Marques AR, Toney JF, Simberkoff MS, Serrao R, Arbeit RD, Gnann JW, Greenberg RN, Holodniy M, Keitel WA, Yeh SS, Davis LE, Crawford GE, Neuzil KM, Johnson GR, Zhang JH, Harbecke R, Chan IS, Keller PM, Williams HM, Boardman KD, Silber JL, Annunziato PW. Safety of zoster vaccine in elderly adults following documented herpes zoster. J Infect Dis. 2013 Aug 15; 208(4):559-63. PMID: 23633406.
      Citations: 15     Fields:    Translation:Humans
    39. Slashinski MJ, Whitney SN, Achenbaum LS, Keitel WA, McCurdy SA, McGuire AL. Investigators' perspectives on translating human microbiome research into clinical practice. Public Health Genomics. 2013; 16(3):127-33. PMID: 23615375.
      Citations: 1     Fields:    Translation:Humans
    40. Nofs SA, Atmar RL, Keitel WA, Hanlon C, Stanton JJ, Tan J, Flanagan JP, Howard L, Ling PD. Prenatal passive transfer of maternal immunity in Asian elephants (Elephas maximus). Vet Immunol Immunopathol. 2013 Jun 15; 153(3-4):308-11. PMID: 23582266.
      Citations: 4     Fields:    Translation:AnimalsPHPublic Health
    41. Aagaard K, Petrosino J, Keitel W, Watson M, Katancik J, Garcia N, Patel S, Cutting M, Madden T, Hamilton H, Harris E, Gevers D, Simone G, McInnes P, Versalovic J. The Human Microbiome Project strategy for comprehensive sampling of the human microbiome and why it matters. FASEB J. 2013 Mar; 27(3):1012-22. PMID: 23165986.
      Citations: 124     Fields:    Translation:HumansCTClinical Trials
    42. Couch RB, Atmar RL, Keitel WA, Quarles JM, Wells J, Arden N, Niño D. Randomized comparative study of the serum antihemagglutinin and antineuraminidase antibody responses to six licensed trivalent influenza vaccines. Vaccine. 2012 Dec 17; 31(1):190-5. PMID: 23107591.
      Citations: 34     Fields:    Translation:HumansPHPublic Health
    43. Patel SM, Atmar RL, El Sahly HM, Guo K, Hill H, Keitel WA. Direct comparison of an inactivated subvirion influenza A virus subtype H5N1 vaccine administered by the intradermal and intramuscular routes. J Infect Dis. 2012 Oct 01; 206(7):1069-77. PMID: 22891287.
      Citations: 10     Fields:    Translation:HumansCellsCTClinical Trials
    44. Stewart B, Rose CE, Tokars JI, Martin SW, Keitel WA, Keyserling HL, Babcock J, Parker SD, Jacobson RM, Poland GA, McNeil MM. Health-related quality of life in the CDC Anthrax Vaccine Adsorbed Human Clinical Trial. Vaccine. 2012 Aug 31; 30(40):5875-9. PMID: 22814409.
      Citations:    Fields:    Translation:HumansPHPublic HealthCTClinical Trials
    45. McGuire AL, Achenbaum LS, Whitney SN, Slashinski MJ, Versalovic J, Keitel WA, McCurdy SA. Perspectives on human microbiome research ethics. J Empir Res Hum Res Ethics. 2012 Jul; 7(3):1-14. PMID: 22850139.
      Citations: 14     Fields:    Translation:Humans
    46. El Sahly HM, Davis C, Kotloff K, Meier J, Winokur PL, Wald A, Johnston C, George SL, Brady RC, Lehmann C, Stokes-Riner A, Keitel WA. Higher antigen content improves the immune response to 2009 H1N1 influenza vaccine in HIV-infected adults: a randomized clinical trial. J Infect Dis. 2012 Mar 01; 205(5):703-12. PMID: 22275399.
      Citations: 13     Fields:    Translation:HumansCells
    47. Jackson LA, Patel SM, Swamy GK, Frey SE, Creech CB, Munoz FM, Artal R, Keitel WA, Noah DL, Petrie CR, Wolff M, Edwards KM. Immunogenicity of an inactivated monovalent 2009 H1N1 influenza vaccine in pregnant women. J Infect Dis. 2011 Sep 15; 204(6):854-63. PMID: 21849282.
      Citations: 45     Fields:    Translation:HumansCellsPHPublic Health
    48. Atmar RL, Keitel WA, Quarles JM, Cate TR, Patel SM, Nino D, Wells J, Arden N, Guo K, Hill H, Couch RB. Evaluation of age-related differences in the immunogenicity of a G9 H9N2 influenza vaccine. Vaccine. 2011 Oct 19; 29(45):8066-72. PMID: 21864622.
      Citations: 6     Fields:    Translation:HumansCells
    49. Bernstein DI, El Sahly HM, Keitel WA, Wolff M, Simone G, Segawa C, Wong S, Shelly D, Young NS, Dempsey W. Safety and immunogenicity of a candidate parvovirus B19 vaccine. Vaccine. 2011 Oct 06; 29(43):7357-63. PMID: 21807052.
      Citations: 14     Fields:    Translation:HumansCellsCTClinical Trials
    50. Atmar RL, Patel SM, Keitel WA. Intanza(®): a new intradermal vaccine for seasonal influenza. Expert Rev Vaccines. 2010 Dec; 9(12):1399-409. PMID: 21105776.
      Citations: 18     Fields:    Translation:HumansPHPublic Health
    51. El Sahly HM, Patel SM, Atmar RL, Lanford TA, Dube T, Thompson D, Sim BK, Long C, Keitel WA. Safety and immunogenicity of a recombinant nonglycosylated erythrocyte binding antigen 175 Region II malaria vaccine in healthy adults living in an area where malaria is not endemic. Clin Vaccine Immunol. 2010 Oct; 17(10):1552-9. PMID: 20702657.
      Citations: 30     Fields:    Translation:HumansAnimalsPHPublic Health
    52. Patel SM, Atmar RL, El Sahly HM, Cate TR, Keitel WA. A phase I evaluation of inactivated influenza A/H5N1 vaccine administered by the intradermal or the intramuscular route. Vaccine. 2010 Apr 09; 28(17):3025-9. PMID: 19931380.
      Citations: 17     Fields:    Translation:HumansCellsCTClinical Trials
    53. Keitel WA, Treanor JJ, El Sahly HM, Gilbert A, Meyer AL, Patriarca PA, Cox MM. Comparative immunogenicity of recombinant influenza hemagglutinin (rHA) and trivalent inactivated vaccine (TIV) among persons > or =65 years old. Vaccine. 2009 Dec 11; 28(2):379-85. PMID: 19879222.
      Citations: 13     Fields:    Translation:Humans
    54. Feng J, Gulati U, Zhang X, Keitel WA, Thompson DM, James JA, Thompson LF, Air GM. Antibody quantity versus quality after influenza vaccination. Vaccine. 2009 Oct 23; 27(45):6358-62. PMID: 19840673.
      Citations: 21     Fields:    Translation:HumansCellsPHPublic Health
    55. Keitel W, Groth N, Lattanzi M, Praus M, Hilbert AK, Borkowski A, Tsai TF. Dose ranging of adjuvant and antigen in a cell culture H5N1 influenza vaccine: safety and immunogenicity of a phase 1/2 clinical trial. Vaccine. 2010 Jan 08; 28(3):840-8. PMID: 19835829.
      Citations: 17     Fields:    Translation:HumansCellsPHPublic Health
    56. Keitel WA, Treanor JJ, El Sahly HM, Evans TG, Kopper S, Whitlow V, Selinsky C, Kaslow DC, Rolland A, Smith LR, Lalor PA. Evaluation of a plasmid DNA-based anthrax vaccine in rabbits, nonhuman primates and healthy adults. Hum Vaccin. 2009 Aug; 5(8):536-44. PMID: 19458488.
      Citations: 6     Fields:    Translation:HumansAnimalsCellsPHPublic HealthCTClinical Trials
    57. Couch RB, Atmar RL, Cate TR, Quarles JM, Keitel WA, Arden NH, Wells J, Niño D, Wyde PR. Contrasting effects of type I interferon as a mucosal adjuvant for influenza vaccine in mice and humans. Vaccine. 2009 Aug 27; 27(39):5344-8. PMID: 19607949.
      Citations: 13     Fields:    Translation:HumansAnimalsCells
    58. Brady RC, Treanor JJ, Atmar RL, Keitel WA, Edelman R, Chen WH, Winokur P, Belshe R, Graham IL, Noah DL, Guo K, Hill H. Safety and immunogenicity of a subvirion inactivated influenza A/H5N1 vaccine with or without aluminum hydroxide among healthy elderly adults. Vaccine. 2009 Aug 13; 27(37):5091-5. PMID: 19577636.
      Citations: 26     Fields:    Translation:HumansCellsPHPublic Health
    59. El Sahly HM, Atmar RL, Patel SM, Wells JM, Cate T, Ho M, Guo K, Pasetti MF, Lewis DE, Sztein MB, Keitel WA. Safety, reactogenicity and immunogenicity of Francisella tularensis live vaccine strain in humans. Vaccine. 2009 Aug 06; 27(36):4905-11. PMID: 19567246.
      Citations: 26     Fields:    Translation:HumansCells
    60. Keitel WA, Dekker CL, Mink C, Campbell JD, Edwards KM, Patel SM, Ho DY, Talbot HK, Guo K, Noah DL, Hill H. Safety and immunogenicity of inactivated, Vero cell culture-derived whole virus influenza A/H5N1 vaccine given alone or with aluminum hydroxide adjuvant in healthy adults. Vaccine. 2009 Nov 05; 27(47):6642-8. PMID: 19773098.
      Citations: 19     Fields:    Translation:HumansAnimalsCells
    61. Reason D, Liberato J, Sun J, Keitel W, Zhou J. Frequency and domain specificity of toxin-neutralizing paratopes in the human antibody response to anthrax vaccine adsorbed. Infect Immun. 2009 May; 77(5):2030-5. PMID: 19223482.
      Citations: 20     Fields:    Translation:HumansAnimalsCells
    62. Atmar RL, Keitel WA. Adjuvants for pandemic influenza vaccines. Curr Top Microbiol Immunol. 2009; 333:323-44. PMID: 19768413.
      Citations: 19     Fields:    Translation:HumansAnimalsCellsPHPublic Health
    63. Keitel WA, Atmar RL. Vaccines for pandemic influenza: summary of recent clinical trials. Curr Top Microbiol Immunol. 2009; 333:431-51. PMID: 19768418.
      Citations: 11     Fields:    Translation:HumansCellsPHPublic Health
    64. Engler RJ, Nelson MR, Klote MM, VanRaden MJ, Huang CY, Cox NJ, Klimov A, Keitel WA, Nichol KL, Carr WW, Treanor JJ. Half- vs full-dose trivalent inactivated influenza vaccine (2004-2005): age, dose, and sex effects on immune responses. Arch Intern Med. 2008 Dec 08; 168(22):2405-14. PMID: 19064822.
      Citations: 92     Fields:    Translation:Humans
    65. Keitel WA, Campbell JD, Treanor JJ, Walter EB, Patel SM, He F, Noah DL, Hill H. Safety and immunogenicity of an inactivated influenza A/H5N1 vaccine given with or without aluminum hydroxide to healthy adults: results of a phase I-II randomized clinical trial. J Infect Dis. 2008 Nov 01; 198(9):1309-16. PMID: 18808338.
      Citations: 32     Fields:    Translation:HumansCellsCTClinical Trials
    66. Marano N, Plikaytis BD, Martin SW, Rose C, Semenova VA, Martin SK, Freeman AE, Li H, Mulligan MJ, Parker SD, Babcock J, Keitel W, El Sahly H, Poland GA, Jacobson RM, Keyserling HL, Soroka SD, Fox SP, Stamper JL, McNeil MM, Perkins BA, Messonnier N, Quinn CP. Effects of a reduced dose schedule and intramuscular administration of anthrax vaccine adsorbed on immunogenicity and safety at 7 months: a randomized trial. JAMA. 2008 Oct 01; 300(13):1532-43. PMID: 18827210.
      Citations: 41     Fields:    Translation:HumansCellsCTClinical Trials
    67. Keitel WA, Atmar RL, Nino D, Cate TR, Couch RB. Increasing doses of an inactivated influenza A/H1N1 vaccine induce increasing levels of cross-reacting antibody to subsequent, antigenically different, variants. J Infect Dis. 2008 Oct 01; 198(7):1016-8. PMID: 18729777.
      Citations: 7     Fields:    Translation:HumansCells
    68. El Sahly HM, Keitel WA. Clinical data on Fluarix: an inactivated split seasonal influenza vaccine. Expert Rev Vaccines. 2008 Aug; 7(6):713-9. PMID: 18665769.
      Citations: 4     Fields:    Translation:HumansCells
    69. Reason DC, Ullal A, Liberato J, Sun J, Keitel W, Zhou J. Domain specificity of the human antibody response to Bacillus anthracis protective antigen. Vaccine. 2008 Jul 29; 26(32):4041-7. PMID: 18565627.
      Citations: 14     Fields:    Translation:HumansAnimalsCells
    70. Talbot HK, Keitel W, Cate TR, Treanor J, Campbell J, Brady RC, Graham I, Dekker CL, Ho D, Winokur P, Walter E, Bennet J, Formica N, Hartel G, Skeljo M, Edwards KM. Immunogenicity, safety and consistency of new trivalent inactivated influenza vaccine. Vaccine. 2008 Jul 29; 26(32):4057-61. PMID: 18602726.
      Citations: 12     Fields:    Translation:HumansCellsCTClinical Trials
    71. El Sahly HM, Keitel WA. Pandemic H5N1 influenza vaccine development: an update. Expert Rev Vaccines. 2008 Mar; 7(2):241-7. PMID: 18324892.
      Citations: 17     Fields:    Translation:HumansAnimalsCellsPHPublic Health
    72. Gorse GJ, Keitel W, Keyserling H, Taylor DN, Lock M, Alves K, Kenner J, Deans L, Gurwith M. Response to letter to the editor "Zink TK. Vaccine 2007;25(15):2766-7". Vaccine. 2007 Oct 16; 25(42):7285-7. PMID: 17850932.
      Citations: 1     Fields:    Translation:Humans
    73. Zhou J, Ullal A, Liberato J, Sun J, Keitel W, Reason DC. Paratope diversity in the human antibody response to Bacillus anthracis protective antigen. Mol Immunol. 2008 Jan; 45(2):338-47. PMID: 17707509.
      Citations: 5     Fields:    Translation:HumansCells
    74. Keitel WA, Atmar RL. Preparing for a possible pandemic: influenza A/H5N1 vaccine development. Curr Opin Pharmacol. 2007 Oct; 7(5):484-90. PMID: 17644429.
      Citations: 12     Fields:    Translation:HumansAnimalsCellsPHPublic Health
    75. Gulati U, Keitel WA, Air GM. Increased antibodies against unfolded viral antigens in the elderly after influenza vaccination. Influenza Other Respir Viruses. 2007 Jul; 1(4):147-56. PMID: 18458742.
      Citations: 4     Fields:    Translation:HumansCells
    76. Atmar RL, Keitel WA, Cate TR, Munoz FM, Ruben F, Couch RB. A dose-response evaluation of inactivated influenza vaccine given intranasally and intramuscularly to healthy young adults. Vaccine. 2007 Jul 20; 25(29):5367-73. PMID: 17559990.
      Citations: 21     Fields:    Translation:Humans
    77. Atmar RL, Keitel WA, Patel SM, Katz JM, She D, El Sahly H, Pompey J, Cate TR, Couch RB. Safety and immunogenicity of nonadjuvanted and MF59-adjuvanted influenza A/H9N2 vaccine preparations. Clin Infect Dis. 2006 Nov 01; 43(9):1135-42. PMID: 17029131.
      Citations: 35     Fields:    Translation:HumansCellsCTClinical Trials
    78. Keitel WA. Recombinant protective antigen 102 (rPA102): profile of a second-generation anthrax vaccine. Expert Rev Vaccines. 2006 Aug; 5(4):417-30. PMID: 16989623.
      Citations: 13     Fields:    Translation:Humans
    79. Gorse GJ, Keitel W, Keyserling H, Taylor DN, Lock M, Alves K, Kenner J, Deans L, Gurwith M. Immunogenicity and tolerance of ascending doses of a recombinant protective antigen (rPA102) anthrax vaccine: a randomized, double-blinded, controlled, multicenter trial. Vaccine. 2006 Aug 14; 24(33-34):5950-9. PMID: 16797805.
      Citations: 39     Fields:    Translation:HumansCTClinical Trials
    80. Ward JI, Cherry JD, Chang SJ, Partridge S, Keitel W, Edwards K, Lee M, Treanor J, Greenberg DP, Barenkamp S, Bernstein DI, Edelman R. Bordetella Pertussis infections in vaccinated and unvaccinated adolescents and adults, as assessed in a national prospective randomized Acellular Pertussis Vaccine Trial (APERT). Clin Infect Dis. 2006 Jul 15; 43(2):151-7. PMID: 16779740.
      Citations: 24     Fields:    Translation:HumansCellsPHPublic Health
    81. Keitel WA, Atmar RL, Cate TR, Petersen NJ, Greenberg SB, Ruben F, Couch RB. Safety of high doses of influenza vaccine and effect on antibody responses in elderly persons. Arch Intern Med. 2006 May 22; 166(10):1121-7. PMID: 16717175.
      Citations: 49     Fields:    Translation:HumansCells
    82. Treanor JJ, Campbell JD, Brady RC, Keitel WA, Drame M, Jain VK, Innis BL. Rapid licensure of a new, inactivated influenza vaccine in the United States. Hum Vaccin. 2005 Nov-Dec; 1(6):239-44. PMID: 17012883.
      Citations: 11     Fields:    Translation:HumansCTClinical Trials
    83. Ward JI, Cherry JD, Chang SJ, Partridge S, Lee H, Treanor J, Greenberg DP, Keitel W, Barenkamp S, Bernstein DI, Edelman R, Edwards K. Efficacy of an acellular pertussis vaccine among adolescents and adults. N Engl J Med. 2005 Oct 13; 353(15):1555-63. PMID: 16221778.
      Citations: 66     Fields:    Translation:HumansCellsCTClinical Trials
    84. Oxman MN, Levin MJ, Johnson GR, Schmader KE, Straus SE, Gelb LD, Arbeit RD, Simberkoff MS, Gershon AA, Davis LE, Weinberg A, Boardman KD, Williams HM, Zhang JH, Peduzzi PN, Beisel CE, Morrison VA, Guatelli JC, Brooks PA, Kauffman CA, Pachucki CT, Neuzil KM, Betts RF, Wright PF, Griffin MR, Brunell P, Soto NE, Marques AR, Keay SK, Goodman RP, Cotton DJ, Gnann JW, Loutit J, Holodniy M, Keitel WA, Crawford GE, Yeh SS, Lobo Z, Toney JF, Greenberg RN, Keller PM, Harbecke R, Hayward AR, Irwin MR, Kyriakides TC, Chan CY, Chan IS, Wang WW, Annunziato PW, Silber JL. A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults. N Engl J Med. 2005 Jun 02; 352(22):2271-84. PMID: 15930418.
      Citations: 589     Fields:    Translation:HumansCellsCTClinical Trials
    85. Gulati U, Kumari K, Wu W, Keitel WA, Air GM. Amount and avidity of serum antibodies against native glycoproteins and denatured virus after repeated influenza whole-virus vaccination. Vaccine. 2005 Feb 03; 23(11):1414-25. PMID: 15661391.
      Citations: 27     Fields:    Translation:Humans
    86. Cherry JD, Chang SJ, Klein D, Lee M, Barenkamp S, Bernstein D, Edelman R, Decker MD, Greenberg DP, Keitel W, Treanor J, Ward JI. Prevalence of antibody to Bordetella pertussis antigens in serum specimens obtained from 1793 adolescents and adults. Clin Infect Dis. 2004 Dec 01; 39(11):1715-8. PMID: 15578376.
      Citations: 4     Fields:    Translation:HumansCells
    87. Le T, Cherry JD, Chang SJ, Knoll MD, Lee ML, Barenkamp S, Bernstein D, Edelman R, Edwards KM, Greenberg D, Keitel W, Treanor J, Ward JI. Immune responses and antibody decay after immunization of adolescents and adults with an acellular pertussis vaccine: the APERT Study. J Infect Dis. 2004 Aug 01; 190(3):535-44. PMID: 15243929.
      Citations: 42     Fields:    Translation:HumansCellsPHPublic HealthCTClinical Trials
    88. Amaya RA, Baker CJ, Keitel WA, Edwards MS. Healthy elderly people lack neutrophil-mediated functional activity to type V group B Streptococcus. J Am Geriatr Soc. 2004 Jan; 52(1):46-50. PMID: 14687314.
      Citations: 5     Fields:    Translation:HumansCells
    89. Ling PD, Vilchez RA, Keitel WA, Poston DG, Peng RS, White ZS, Visnegarwala F, Lewis DE, Butel JS. Epstein-Barr virus DNA loads in adult human immunodeficiency virus type 1-infected patients receiving highly active antiretroviral therapy. Clin Infect Dis. 2003 Nov 01; 37(9):1244-9. PMID: 14557970.
      Citations: 19     Fields:    Translation:HumansCells
    90. Walling DM, Brown AL, Etienne W, Keitel WA, Ling PD. Multiple Epstein-Barr virus infections in healthy individuals. J Virol. 2003 Jun; 77(11):6546-50. PMID: 12743312.
      Citations: 35     Fields:    Translation:HumansCells
    91. Munoz FM, Keitel WA. Progress in the Diagnosis, Prevention, and Treatment of Pertussis. Curr Infect Dis Rep. 2003 Jun; 5(3):213-219. PMID: 12760818.
      Citations: 3     
    92. Ling PD, Lednicky JA, Keitel WA, Poston DG, White ZS, Peng R, Liu Z, Mehta SK, Pierson DL, Rooney CM, Vilchez RA, Smith EO, Butel JS. The dynamics of herpesvirus and polyomavirus reactivation and shedding in healthy adults: a 14-month longitudinal study. J Infect Dis. 2003 May 15; 187(10):1571-80. PMID: 12721937.
      Citations: 54     Fields:    Translation:HumansCells
    93. Lednicky JA, Vilchez RA, Keitel WA, Visnegarwala F, White ZS, Kozinetz CA, Lewis DE, Butel JS. Polyomavirus JCV excretion and genotype analysis in HIV-infected patients receiving highly active antiretroviral therapy. AIDS. 2003 Apr 11; 17(6):801-7. PMID: 12660526.
      Citations: 9     Fields:    Translation:HumansCells
    94. Keitel WA. Repeated immunization of children with inactivated and live attenuated influenza virus vaccines: safety, immunogenicity, and protective efficacy. Semin Pediatr Infect Dis. 2002 Apr; 13(2):112-9. PMID: 12122949.
      Citations: 3     Fields:    Translation:HumansCells
    95. Lee EA, Palmer DR, Flanagan KL, Reece WH, Odhiambo K, Marsh K, Pinder M, Gravenor MB, Keitel WA, Kester KE, Diggs C, Kaslow D, Apostolopoulos V, Ballou WR, Hill AV, Krzych U, Plebanski M. Induction of T helper type 1 and 2 responses to 19-kilodalton merozoite surface protein 1 in vaccinated healthy volunteers and adults naturally exposed to malaria. Infect Immun. 2002 Mar; 70(3):1417-21. PMID: 11854228.
      Citations: 16     Fields:    Translation:HumansCellsPHPublic HealthCTClinical Trials
    96. Treanor J, Keitel W, Belshe R, Campbell J, Schiff G, Zangwill K, Wolff M, Klimov A, Levandowski R, Lambert L. Evaluation of a single dose of half strength inactivated influenza vaccine in healthy adults. Vaccine. 2002 Jan 15; 20(7-8):1099-105. PMID: 11803070.
      Citations: 21     Fields:    Translation:HumansCTClinical Trials
    97. Keitel WA, Cate TR, Nino D, Huggins LL, Six HR, Quarles JM, Couch RB. Immunization against influenza: comparison of various topical and parenteral regimens containing inactivated and/or live attenuated vaccines in healthy adults. J Infect Dis. 2001 Jan 15; 183(2):329-332. PMID: 11110645.
      Citations: 7     Fields:    Translation:HumansCellsPHPublic HealthCTClinical Trials
    98. Weingart CL, Keitel WA, Edwards KM, Weiss AA. Characterization of bactericidal immune responses following vaccination with acellular pertussis vaccines in adults. Infect Immun. 2000 Dec; 68(12):7175-9. PMID: 11083851.
      Citations: 14     Fields:    Translation:HumansCellsPHPublic Health
    99. Keitel WA, Kester KE, Atmar RL, White AC, Bond NH, Holland CA, Krzych U, Palmer DR, Egan A, Diggs C, Ballou WR, Hall BF, Kaslow D. Phase I trial of two recombinant vaccines containing the 19kd carboxy terminal fragment of Plasmodium falciparum merozoite surface protein 1 (msp-1(19)) and T helper epitopes of tetanus toxoid. Vaccine. 1999 Oct 14; 18(5-6):531-9. PMID: 10519944.
      Citations: 28     Fields:    Translation:HumansAnimalsCellsCTClinical Trials
    100. Keitel WA, Muenz LR, Decker MD, Englund JA, Mink CM, Blumberg DA, Edwards KM. A randomized clinical trial of acellular pertussis vaccines in healthy adults: dose-response comparisons of 5 vaccines and implications for booster immunization. J Infect Dis. 1999 Aug; 180(2):397-403. PMID: 10395855.
      Citations: 11     Fields:    Translation:HumansCellsCTClinical Trials
    101. Keitel WA. Cellular and acellular pertussis vaccines in adults. Clin Infect Dis. 1999 Jun; 28 Suppl 2:S118-23. PMID: 10447029.
      Citations: 10     Fields:    Translation:HumansPHPublic Health
    102. Keitel WA, Edwards KM. Acellular pertussis vaccines in adults. Infect Dis Clin North Am. 1999 Mar; 13(1):83-94, vi. PMID: 10198793.
      Citations: 1     Fields:    Translation:HumansCells
    103. Couch RB, Keitel WA, Cate TR. Improvement of inactivated influenza virus vaccines. J Infect Dis. 1997 Aug; 176 Suppl 1:S38-44. PMID: 9240693.
      Citations: 14     Fields:    Translation:Humans
    104. Keitel WA, Cate TR, Couch RB, Huggins LL, Hess KR. Efficacy of repeated annual immunization with inactivated influenza virus vaccines over a five year period. Vaccine. 1997 Jul; 15(10):1114-22. PMID: 9269055.
      Citations: 65     Fields:    Translation:HumansCellsPHPublic HealthCTClinical Trials
    105. Keitel WA, Cate TR, Atmar RL, Turner CS, Nino D, Dukes CM, Six HR, Couch RB. Increasing doses of purified influenza virus hemagglutinin and subvirion vaccines enhance antibody responses in the elderly. Clin Diagn Lab Immunol. 1996 Sep; 3(5):507-10. PMID: 8877126.
      Citations: 16     Fields:    Translation:HumansCTClinical Trials
    106. Keitel W. Hepatitis delta virus: an important human pathogen. Clin Infect Dis. 1996 Mar; 22(3):605. PMID: 8853009.
      Citations:    Fields:    Translation:HumansCells
    107. Khan AS, Polezhaev F, Vasiljeva R, Drinevsky V, Buffington J, Gary H, Sominina A, Keitel W, Regnery H, Lonskaya NL, Doroshenko E, Gavrilov A, Ivakhov I, Arden N, Schonberger LB, Couch R, Kendal A, Cox N. Comparison of US inactivated split-virus and Russian live attenuated, cold-adapted trivalent influenza vaccines in Russian schoolchildren. J Infect Dis. 1996 Feb; 173(2):453-6. PMID: 8568310.
      Citations: 13     Fields:    Translation:HumansCellsPHPublic HealthCTClinical Trials
    108. Musher DM, Keitel WA. Severe paroxysmal coughing and pleuritic pain in an adult. Hosp Pract (1995). 1995 Dec 15; 30(12):65-7. PMID: 8522629.
      Citations:    Fields:    Translation:Humans
    109. Kilbourne ED, Couch RB, Kasel JA, Keitel WA, Cate TR, Quarles JH, Grajower B, Pokorny BA, Johansson BE. Purified influenza A virus N2 neuraminidase vaccine is immunogenic and non-toxic in humans. Vaccine. 1995 Dec; 13(18):1799-803. PMID: 8701596.
      Citations: 27     Fields:    Translation:HumansCellsCTClinical Trials
    110. Atmar RL, Keitel WA, Cate TR, Quarles JM, Couch RB. Comparison of trivalent cold-adapted recombinant (CR) influenza virus vaccine with monovalent CR vaccines in healthy unselected adults. J Infect Dis. 1995 Jul; 172(1):253-7. PMID: 7797925.
      Citations: 3     Fields:    Translation:HumansCellsCTClinical Trials
    111. Keitel WA, Edwards KM. Pertussis in adolescents and adults: time to reimmunize? Semin Respir Infect. 1995 Mar; 10(1):51-7. PMID: 7761714.
      Citations: 5     Fields:    Translation:Humans
    112. Langlois PH, Smolensky MH, Glezen WP, Keitel WA. Diurnal variation in responses to influenza vaccine. Chronobiol Int. 1995 Feb; 12(1):28-36. PMID: 7750155.
      Citations: 8     Fields:    Translation:HumansPHPublic Health
    113. Keitel WA, Couch RB, Cate TR, Hess KR, Baxter B, Quarles JM, Atmar RL, Six HR. High doses of purified influenza A virus hemagglutinin significantly augment serum and nasal secretion antibody responses in healthy young adults. J Clin Microbiol. 1994 Oct; 32(10):2468-73. PMID: 7814484.
      Citations: 25     Fields:    Translation:HumansCTClinical Trials
    114. Keitel WA, Couch RB, Cate TR, Maassab HF. Variability in infectivity of cold-adapted recombinant influenza virus vaccines in humans. J Infect Dis. 1994 Feb; 169(2):477. PMID: 8106789.
      Citations: 3     Fields:    Translation:HumansCells
    115. Keitel WA, Bond NL, Zahradnik JM, Cramton TA, Robbins JB. Clinical and serological responses following primary and booster immunization with Salmonella typhi Vi capsular polysaccharide vaccines. Vaccine. 1994; 12(3):195-9. PMID: 8165850.
      Citations: 22     Fields:    Translation:HumansPHPublic HealthCTClinical Trials
    116. Keitel WA, Couch RB, Quarles JM, Cate TR, Baxter B, Maassab HF. Trivalent attenuated cold-adapted influenza virus vaccine: reduced viral shedding and serum antibody responses in susceptible adults. J Infect Dis. 1993 Feb; 167(2):305-11. PMID: 8421165.
      Citations: 6     Fields:    Translation:HumansCellsPHPublic HealthCTClinical Trials
    117. Keitel W, Couch R, Bond N, Adair S, Van Nest G, Dekker C. Pilot evaluation of influenza virus vaccine (IVV) combined with adjuvant. Vaccine. 1993; 11(9):909-13. PMID: 8212835.
      Citations: 6     Fields:    Translation:HumansAnimalsCellsCTClinical Trials
    118. Glezen WP, Keitel WA, Taber LH, Piedra PA, Clover RD, Couch RB. Age distribution of patients with medically-attended illnesses caused by sequential variants of influenza A/H1N1: comparison to age-specific infection rates, 1978-1989. Am J Epidemiol. 1991 Feb 01; 133(3):296-304. PMID: 2000847.
      Citations: 28     Fields:    Translation:HumansCells
    119. Atmar RL, Bloom K, Keitel W, Couch RB, Greenberg SB. Effect of live attenuated, cold recombinant (CR) influenza virus vaccines on pulmonary function in healthy and asthmatic adults. Vaccine. 1990 Jun; 8(3):217-24. PMID: 2194380.
      Citations: 7     Fields:    Translation:HumansCTClinical Trials
    120. Keitel WA, Couch RB, Cate TR, Six HR, Baxter BD. Cold recombinant influenza B/Texas/1/84 vaccine virus (CRB 87): attenuation, immunogenicity, and efficacy against homotypic challenge. J Infect Dis. 1990 Jan; 161(1):22-6. PMID: 2153185.
      Citations: 9     Fields:    Translation:HumansCellsCTClinical Trials
    121. Harmon MW, Jones I, Shaw M, Keitel W, Reimer CB, Halonen P, Kendal AP. Immunoassay for serologic diagnosis of influenza type A using recombinant DNA produced nucleoprotein antigen and monoclonal antibody to human IgG. J Med Virol. 1989 Jan; 27(1):25-30. PMID: 2646393.
      Citations: 3     Fields:    Translation:HumansCells
    122. Keitel WA, Cate TR, Couch RB. Efficacy of sequential annual vaccination with inactivated influenza virus vaccine. Am J Epidemiol. 1988 Feb; 127(2):353-64. PMID: 3337087.
      Citations: 29     Fields:    Translation:HumansPHPublic HealthCTClinical Trials
    123. Couch RB, Kasel JA, Glezen WP, Cate TR, Six HR, Taber LH, Frank AL, Greenberg SB, Zahradnik JM, Keitel WA. Influenza: its control in persons and populations. J Infect Dis. 1986 Mar; 153(3):431-40. PMID: 3950437.
      Citations: 36     Fields:    Translation:HumansPHPublic Health
    124. Kasel JA, Frank AL, Keitel WA, Taber LH, Glezen WP. Acquisition of serum antibodies to specific viral glycoproteins of parainfluenza virus 3 in children. J Virol. 1984 Dec; 52(3):828-32. PMID: 6092715.
      Citations: 10     Fields:    Translation:HumansCells
    KEITEL's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (359)
    Explore
    _
    Co-Authors (25)
    Explore
    _
    Similar People (60)
    Explore
    _
    Same Department Expand Description
    Explore
    _
    Physical Neighbors
    _